RxDoctor Payments Data

Jennifer Sewing, DO

Family Medicine · Saint Louis, MONPI 1689655060

Payments from drug & device makers

$9,880in general payments, 2019–2025

Across 648 payments — averaging $15.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$1K
  • Novo Nordisk$1K
  • AbbVie$1K
  • Lilly USA, LLC$908
  • Pfizer$859
  • Boehringer Ingelheim$467
  • plus $4K from 48 others

What the payments were for

  • Food & beverage$9,865100%
  • Entertainment$150%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,880 in reported general payments places this provider in the 90th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$27,393
Medicare patients
65
Services billed
912

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban214$160,849
OzempicSemaglutide78$78,192
MounjaroTirzepatide70$74,782
Trelegy ElliptaFluticasone/Umeclidin/Vilanter50$36,792
FarxigaDapagliflozin Propanediol43$31,557
Dabigatran EtexilateDabigatran Etexilate Mesylate85$28,681
ProliaDenosumab15$25,555
TradjentaLinagliptin38$25,062
XareltoRivaroxaban37$24,855
MyrbetriqMirabegron41$19,878
JardianceEmpagliflozin17$19,104
Buprenorphine67$12,877
Mirabegron ErMirabegron19$11,460
ArexvyRsvpref3 Antigen/As01e/Pf39$11,236
Breztri AerosphereBudesonide/Glycopyr/Formoterol11$10,388

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$859$160,849214 claims
Novo NordiskOzempic$1,107$78,19278 claims
Lilly USA, LLCMounjaro$908$74,78270 claims
GSKTrelegy Ellipta, Arexvy, Anoro Ellipta$1,364$55,416105 claims
Boehringer IngelheimTradjenta, Jardiance$467$44,16655 claims
AstraZenecaFarxiga, Breztri Aerosphere$416$41,94554 claims
AmgenProlia$274$25,55515 claims
Johnson & JohnsonXarelto$189$24,85537 claims
Astellas Pharma US IncMyrbetriq$184$19,87841 claims
MerckJanuvia$144$6,69312 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in Saint Louis

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →